• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢喹肟在黄牛组织笼模型中对多杀性巴氏杆菌的药代动力学/药效学关系

Pharmacokinetic/pharmacodynamic relationship of cefquinome against Pasteurella multocida in a tissue-cage model in yellow cattle.

作者信息

Shan Q, Yang F, Wang J, Ding H, He L, Zeng Z

机构信息

National Reference Laboratory of Veterinary Drug Residues (SCAU), College of Veterinary Medicine, South China Agricultural University, Guangzhou, China; Pearl River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Guangzhou, China.

出版信息

J Vet Pharmacol Ther. 2014 Apr;37(2):178-85. doi: 10.1111/jvp.12076. Epub 2013 Aug 26.

DOI:10.1111/jvp.12076
PMID:23980645
Abstract

The cephalosporin antimicrobial drug cefquinome was administered to yellow cattle intravenously (i.v.) and intramuscularly (i.m.) at a dose of 1 mg/kg of body weight in a two-period crossover study. The pharmacokinetic (PK) properties of cefquinome in serum, inflamed tissue-cage fluid (exudate), and noninflamed tissue-cage fluid (transudate) were studied using a tissue-cage model. The in vitro and ex vivo activities of cefquinome in serum, exudate, and transudate against a pathogenic strain of Pasteurella multocida (P. multocida) were determined. A concentration-independent antimicrobial activity of cefquinome was confirmed for levels lower than 4 × MIC. Integration of in vivo pharmacokinetic data with the in vitro MIC provided mean values for the time that drug levels remain above the MIC (T > MIC) in serum was 14.10 h after intravenous and 14.46 h after intramuscular dosing, indicating a likely high level of effectiveness in clinical infections caused by P. multocida of MIC 0.04 μg/mL or less. These data may be used as a rational basis for setting dosing schedules, which optimize clinical efficacy and minimize the opportunities for emergence of resistant organisms.

摘要

在一项两阶段交叉研究中,以1毫克/千克体重的剂量对黄牛静脉注射(i.v.)和肌肉注射(i.m.)头孢喹肟这种头孢菌素类抗菌药物。使用组织笼模型研究了头孢喹肟在血清、炎症组织笼液(渗出液)和非炎症组织笼液(漏出液)中的药代动力学(PK)特性。测定了头孢喹肟在血清、渗出液和漏出液中对多杀巴斯德氏菌(P. multocida)致病菌株的体外和离体活性。对于低于4×MIC的水平,证实了头孢喹肟具有浓度依赖性抗菌活性。将体内药代动力学数据与体外MIC相结合,得出静脉给药后血清中药物水平保持高于MIC(T>MIC)的时间平均值为14.10小时,肌肉注射给药后为14.46小时,这表明对MIC为0.04μg/mL或更低的多杀巴斯德氏菌引起的临床感染可能具有较高的有效性。这些数据可作为制定给药方案的合理依据,以优化临床疗效并尽量减少耐药菌出现的机会。

相似文献

1
Pharmacokinetic/pharmacodynamic relationship of cefquinome against Pasteurella multocida in a tissue-cage model in yellow cattle.头孢喹肟在黄牛组织笼模型中对多杀性巴氏杆菌的药代动力学/药效学关系
J Vet Pharmacol Ther. 2014 Apr;37(2):178-85. doi: 10.1111/jvp.12076. Epub 2013 Aug 26.
2
Pharmacokinetic/pharmacodynamic relationship of marbofloxacin against Pasteurella multocida in a tissue-cage model in yellow cattle.在黄牛组织笼模型中,马波沙星对多杀性巴氏杆菌的药代动力学/药效学关系
J Vet Pharmacol Ther. 2014 Jun;37(3):222-30. doi: 10.1111/jvp.12078. Epub 2013 Aug 26.
3
Pharmacokinetic/pharmacodynamic integration of cefquinome against Pasteurella Multocida in a piglet tissue cage model.头孢喹肟在仔猪组织笼模型中对多杀性巴氏杆菌的药代动力学/药效学整合
J Vet Pharmacol Ther. 2019 Jan;42(1):60-66. doi: 10.1111/jvp.12705. Epub 2018 Nov 8.
4
Pharmacokinetic/pharmacodynamic integration and modelling of amoxicillin for the calf pathogens Mannheimia haemolytica and Pasteurella multocida.阿莫西林对犊牛病原菌溶血曼氏杆菌和多杀性巴氏杆菌的药代动力学/药效学整合及建模
J Vet Pharmacol Ther. 2015 Oct;38(5):457-70. doi: 10.1111/jvp.12207. Epub 2015 Feb 9.
5
Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of marbofloxacin in calf serum, exudate and transudate.马波沙星在犊牛血清、渗出液和漏出液中的药代动力学及药代动力学/药效学整合
J Vet Pharmacol Ther. 2002 Jun;25(3):161-74. doi: 10.1046/j.1365-2885.2002.00399.x.
6
PK-PD integration and modeling of marbofloxacin in sheep.玛波沙星在绵羊体内的药动-药效整合与模型研究。
Res Vet Sci. 2010 Feb;88(1):134-41. doi: 10.1016/j.rvsc.2009.05.013. Epub 2009 Jun 11.
7
Pharmacokinetic-pharmacodynamic integration and modelling of oxytetracycline for the calf pathogens Mannheimia haemolytica and Pasteurella multocida.土霉素对犊牛病原菌溶血曼氏杆菌和多杀性巴氏杆菌的药代动力学-药效学整合与建模
J Vet Pharmacol Ther. 2018 Feb;41(1):28-38. doi: 10.1111/jvp.12439. Epub 2017 Jul 23.
8
Pharmacodynamics of marbofloxacin for calf pneumonia pathogens.马波沙星对犊牛肺炎病原菌的药效学研究。
Res Vet Sci. 2013 Jun;94(3):675-81. doi: 10.1016/j.rvsc.2012.12.012. Epub 2013 Jan 31.
9
Pharmacodynamics of amoxicillin against Mannheimia haemolytica and Pasteurella multocida and pharmacokinetic/pharmacodynamic (PK/PD) correlation in sheep.阿莫西林对溶血曼海姆菌和多杀巴斯德菌的药效学及绵羊体内药代动力学/药效学(PK/PD)相关性。
Res Vet Sci. 2010 Dec;89(3):418-25. doi: 10.1016/j.rvsc.2010.03.018. Epub 2010 Apr 3.
10
Pharmacokinetics of cefquinome in healthy and Pasteurella multocida-infected rabbits.头孢喹肟在健康兔和多杀性巴氏杆菌感染兔体内的药代动力学
J Vet Pharmacol Ther. 2018 Jun;41(3):374-377. doi: 10.1111/jvp.12489. Epub 2018 Jan 31.

引用本文的文献

1
Pharmacokinetic and pharmacodynamic integration and resistance analysis of cefquinome against dynamic model.头孢喹肟对动态模型的药代动力学与药效学整合及耐药性分析
Front Microbiol. 2025 Jul 23;16:1533892. doi: 10.3389/fmicb.2025.1533892. eCollection 2025.
2
Ex Vivo Pharmacokinetic/Pharmacodynamic Integration Model of Cefquinome Against in Foals.头孢喹肟对马驹的体外药代动力学/药效学整合模型
Vet Sci. 2025 Mar 22;12(4):294. doi: 10.3390/vetsci12040294.
3
Pharmacokinetic/pharmacodynamic integration of tilmicosin against in a piglet tissue cage model.
替米考星在仔猪组织笼模型中对……的药代动力学/药效学整合
Front Vet Sci. 2023 Sep 4;10:1260990. doi: 10.3389/fvets.2023.1260990. eCollection 2023.
4
Pharmacokinetics and Pharmacodynamics Modeling and Optimal Regimens Evaluation of Cefquinome Against Bovine Mastitis Caused by .头孢喹肟对由……引起的牛乳腺炎的药代动力学和药效学建模及最佳给药方案评估
Front Vet Sci. 2022 Mar 8;9:837882. doi: 10.3389/fvets.2022.837882. eCollection 2022.
5
Disposition of Cefquinome in Turkeys () Following Intravenous and Intramuscular Administration.头孢喹肟在火鸡体内静脉注射和肌肉注射后的处置情况
Pharmaceutics. 2021 Oct 28;13(11):1804. doi: 10.3390/pharmaceutics13111804.
6
Pharmacokinetics, bioavailability and dose assessment of Cefquinome against Escherichia coli in black swans (Cygnus atratus).头孢喹诺对黑天鹅(黑天鹅属)大肠杆菌的药代动力学、生物利用度及剂量评估
BMC Vet Res. 2017 Jul 28;13(1):226. doi: 10.1186/s12917-017-1148-7.
7
In vitro susceptibility of four antimicrobials against Riemerella anatipestifer isolates: a comparison of minimum inhibitory concentrations and mutant prevention concentrations for ceftiofur, cefquinome, florfenicol, and tilmicosin.四种抗菌药物对鸭疫里默氏菌分离株的体外敏感性:头孢噻呋、头孢喹肟、氟苯尼考和替米考星的最低抑菌浓度与突变预防浓度比较
BMC Vet Res. 2016 Nov 9;12(1):250. doi: 10.1186/s12917-016-0796-3.
8
In Vivo Pharmacokinetics/Pharmacodynamics of Cefquinome in an Experimental Mouse Model of Staphylococcus Aureus Mastitis following Intramammary Infusion.乳房内注入后头孢喹肟在金黄色葡萄球菌乳腺炎实验小鼠模型中的体内药代动力学/药效学
PLoS One. 2016 May 24;11(5):e0156273. doi: 10.1371/journal.pone.0156273. eCollection 2016.
9
Integration of PK/PD for dose optimization of Cefquinome against Staphylococcus aureus causing septicemia in cattle.整合药代动力学/药效学以优化头孢喹肟对牛败血症金黄色葡萄球菌的给药剂量。
Front Microbiol. 2015 Jun 17;6:588. doi: 10.3389/fmicb.2015.00588. eCollection 2015.